Beyond the finish line - Dr Andrew Rut in PharmaTimes

Beyond the finish line - Dr Andrew Rut in PharmaTimes


Dr Andrew Rut in PharmaTimes magazine - January 2021

How can pharma help drive COVID-19 vaccination adherence?

The authorisation of Pfizer/BioNTech, Moderna and now Oxford/AstraZeneca COVID-19 vaccines has brought much needed hope in the face of rapidly rising COVID-19 infection rates around the world. It is a truly remarkable achievement that the pharmaceutical industry has transformed its drug discovery and development to launch vaccines in less than 12 months and deliver headline efficacy rates of circa 95%.

However, market authorisation is simply one leg in a relay race. The next stage will be managing the wave of information requests and safety reports that must be expected as part of the COVID-19 mass vaccination campaigns...

Click here to read the full article in PharmaTimes

Request More Information

To find out more or request a demo fill in the details below:

By submitting your information, you are consenting to receive communications from MyMeds&Me. You may at any time 'opt out' of receiving these marketing communications by emailing